跳至主要内容
临床试验/NCT03816202
NCT03816202已完成不适用

Sundt™ Carotid Shunt Retrospective Post Market Clinical Follow-up Study (PMCF)

Integra LifeSciences Corporation3 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2019年4月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
3
主要终点
Evidence of Injury to the Artery or Cerebral Ischemia Secondary to Shunt Placement and Removal

研究概览

简要总结

The primary objective of this study is to retrospectively investigate the safety and efficacy of the Integra Sundt™ carotid shunt during endarterectomy procedures.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Between the ages of 18-80 years old
  • Have undergone carotid endarterectomy with any Integra Sundt™ carotid shunt on or before date of study initiation
  • Availability of records on post-operative imaging of the carotid artery either by carotid duplex ultrasound or angiogram

排除标准

  • Insertion of a carotid shunt at the site of an infection

结局指标

主要结局

Evidence of Injury to the Artery or Cerebral Ischemia Secondary to Shunt Placement and Removal

时间窗: up to 60 days post-procedure

Number of participants with injury to the artery or cerebral ischemia secondary to shunt placement and removal

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验